CRIPTO and its signaling partner GRP78 drive the metastatic phenotype in human osteotropic prostate cancer
Oncogene 36, 4739 (17 August 2017). doi:10.1038/onc.2017.87
Authors: E Zoni, L Chen, S Karkampouna, Z Granchi, E I Verhoef, F La Manna, J Kelber, R C M Pelger, M D Henry, E Snaar-Jagalska, G J L H van Leenders, L Beimers, P Kloen, P C Gray, G van der Pluijm & M Kruithof-de Julio
from # All Medicine by Alexandros G. Sfakianakis via alkiviadis.1961 on Inoreader http://ift.tt/2vGZ8aL
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.